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Article focus
  The use of outcome measures to qualify 
success following total hip arthroplasty; 
specifically to assess the responsiveness 
of the Forgotten Joint Score – 12 in a 
United Kingdom population.
Key messages
  The FJS-12 is more responsive to change 
between six and 12 months after total hip 
arthroplasty and demonstrates half the 
ceiling effects of the oxford hip Score.
  Use of a more sensitive score has material 
implications in detecting differences in 
patient outcome over time.
  Use of an outcome measure with greater 
measurement range and precision allows 
for more specific studies with smaller 
numbers of participants, which has sig-
nificant benefits for researchers and 
funders, allowing for quicker and cheaper 
studies.
Strengths and limitations
  This study is the first specific evaluation of 
the methodological qualities of the FJS-12 
in a United Kingdom or European popu-
lation of hip arthroplasty patients.
  The FJS-12 was described as a post- 
operative outcome score, however the 
use of pre-operative data, would offer 
additional perspective in terms of 
assessing change in score following 
surgery.
Responsiveness and ceiling effects of the 
Forgotten Joint score-12 following total 
hip arthroplasty
Objectives
To assess the responsiveness and ceiling/floor effects of the Forgotten Joint score -12 and to 
compare these with that of the more widely used oxford Hip score (oHs) in patients six and 
12 months after primary total hip arthroplasty.
Methods
We prospectively collected data at six and 12 months following total hip arthroplasty from 
193 patients undergoing surgery at a single centre. ceiling effects are outlined with fre-
quencies for patients obtaining the lowest or highest possible score. change over time from 
six months to 12 months post-surgery is reported as effect size (cohen’s d).
Results
The mean oHs improved from 40.3 (sd 7.9) at six months to 41.9 (sd 7.2) at 12 months. The 
mean FJs-12 improved from 56.8 (sd 30.1) at six months to 62.1 (sd 29.0) at 12 months. 
At six months, 15.5% of patients reached the best possible score (48 points) on the oHs 
and 8.3% obtained the best score (100 points) on the FJs-12. At 12 months, this percent-
age increased to 20.8% for the oHs and to 10.4% for the FJs-12. In terms of the effect size 
(cohen’s d), the change was d = 0.10 for the oHs and d = 0.17 for the FJs-12.
Conclusions
The FJs-12 is more responsive to change between six and 12 months following total hip arthro-
plasty than is the oHs, with the measured ceiling effect for the oHs twice that of the FJs-12. 
The difference in effect size of change results in substantial differences in required sample size 
if aiming to detect change between these two time points. This has important implications for 
powering clinical trials with patient-reported measures as the primary outcome.
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Introduction
Patient-reported outcome measures (PRoms) are a key 
parameter for assessing outcome following total hip 
arthroplasty. PRoms are widely used to power clinical 
studies and increasingly complement implant survivor-
ship in national joint registries, providing a measure of a 
patient's pain and physical function.1,2
There is a plethora of potential patient outcome tools 
that can be employed, which, though similar, offer a 
unique perspective on patient outcome. There is no con-
sensus as to which scores ‘should’ be used, and research-
ers typically revert to the most commonly reported scores 
such as (for hip arthroplasty) the oxford hip Score (ohS)3 
or harris hip Score4
PRom questionnaires differ substantially in their abil-
ity to capture change following joint replacement 
 surgery.5,6 The sensitivity of a score to detect change is 
critical in determining the level of function a patient has 
achieved. ceiling effects in a scoring system can hide dif-
ferences when patients already record the maximum pos-
sible score and cannot improve on that score. For 
example, in a score that simply assesses whether patients 
can walk for more than 30 minutes without pain, a 
75-year-old patient able to walk for just 30 minutes at a 
normal pace would have the same score as a 45-year-old 
patient who has returned to running marathons.
When designing clinical outcome studies, the respon-
siveness of a score is of key importance in determining 
which score is used to power the study, as this materially 
affects the sample size required. Responsive scores are 
required as the symptom burden and range of functional 
impairments define whether ceiling effects will reduce 
the discriminatory power of the employed PRom. In 
terms of assessing the outcome of joint arthroplasty, a 
measure should have a measurement range that is 
responsive across the patient’s surgical pathway, includ-
ing pre-operative and longitudinal post-operative 
outcomes.
a new joint-specific score, the Forgotten Joint Score-
12 (FJS-12),7 was introduced in 2012 to asses a novel 
construct, ‘joint awareness’. The authors of this score 
suggested that the new construct would be more respon-
sive to higher level functional outcomes after joint arthro-
plasty, because being able to ‘forget’ the joint during 
daily life is perhaps the ultimate goal following joint 
replacement surgery.
The objective of this study was to assess the respon-
siveness and ceiling effects of the Forgotten Joint Score-
12 and compare these measures with that of the more 
widely used oxford hip Score in patients six and 12 
months following primary total hip arthroplasty.
patients and Methods
Sample. Patients undergoing total hip arthroplasty over 
a six-month period (January 2013 to June 2013) at a sin-
gle large orthopaedic teaching hospital were assessed 
six and 12 months post-surgery using the ohS and 
the FJS-12. The study centre is the only hospital receiv-
ing adult referrals for a predominantly urban popula-
tion of approximately 850 000. Data had been collected 
through informed consent for inclusion in a departmen-
tal database for which regional ethical approval had been 
obtained (ref 11/al/0079). Procedures were carried out 
by multiple consultant orthopaedic surgeons and their 
supervised trainees. all data was collected independently 
from the clinical team by the arthroplasty outcomes 
research unit of the associated university. all patients 
completed pre-operative outcome questionnaires in 
clinic and by postal follow-up questionnaires at six and 
12 months post-operatively. Demographic data includ-
ing age, gender and comorbidities, were reported by the 
patient as part of the survey.
Assessment instruments. The Forgotten Joint Score-12 
is a recently published patient-reported outcome scale 
designed to assess joint awareness in hips and knees 
during various activities of daily living. It uses a five-
point likert response format, consisting of 12 equally 
weighted questions with the raw score transformed to 
range from zero to 100 points. high scores indicate 
good outcome, i.e. a high degree of being able to for-
get about the affected joint in daily life. In previous 
studies the score has shown good reliability and con-
vergent validity,7,8 performed well in known-group 
comparisons, and was found to be sensitive to change 
over time.6
The oxford hip Score consists of 12 questions relating 
to the patient's perceived pain and functional ability, 
answered on a likert scale with values from zero to four. 
The score ranges from zero to 48, with the overall score 
calculated from the responses to the 12 questions. 
a score of zero is the worst possible outcome, suggesting 
severe symptoms and dysfunction, while 48 is the best 
possible outcome. It is widely used and has been shown 
to have good reliability, validity and responsiveness to 
clinical change.5,9
Statistical analysis. Descriptive statistics are presented as 
frequencies, means, standard deviations (sd) and ranges. 
ceiling effects are described as the frequencies for patients 
obtaining the highest possible score on a PRom. change 
over time, from six months to 12 months post-surgery, 
are presented as effect size (cohen’s d). Effect sizes were 
assessed for the whole cohort and in age, gender, and 
comorbid case-mix subgroups. Statistical analysis was 
conducted with SPSS 21.0 and power analysis with G* 
Power 3.1.10
Results
patient characteristics. Within the study period we col-
lected ohS and FJS-12 data from 193 patients. mean age 
was 67.6 years (sd 10.5) and 116 (60.1%) were female. 
Body mass index at study inclusion was 27.7 on aver-
age (sd 5.2). The most frequent self-reported comorbid 
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conditions were back pain (56.0%), high blood pressure 
(41.1%), depression (20.6%) and heart disease (11.8%). 
of these patients, 19.9% reported no comorbid condi-
tions, 37.6% one comorbidity, and 42.5% two or more 
comorbidities (Table I).
Sensitivity to change over time. The mean ohS improved 
from 40.3 (sd 7.9) at six months to 41.9 (sd 7.2) at 12 
months. mean FJS-12 improved from 56.8 (sd 30.1) at six 
months to 62.1 (sd 29.0) at 12 months (Table II). at six 
months, 15.5% of the patients reached the best possible 
score (48 points) on the ohS and 8.3% obtained the best 
score (100 points) on the FJS-12. at 12 months, this per-
centage increased to 20.8% for the ohS and to 10.4% for 
the FJS-12 (Figs 1 and 2).
In terms of the effect size (cohen’s d), the change was 
d = 0.10 for the ohS and d = 0.17 for the FJS-12. In a 
power analysis for the comparison of two time points 
(t-test for dependent sample, power = 0.80, alpha = 0.05, 
two-sided), the required sample size to detect a differ-
ence between six and 12 months is 787 patients for the 
ohS and 262 patients for the FJS-12.
Subgroup analysis. We found the ohS to have the same 
change over time in men and women (cohen’s d = 0.10 
in both groups). The FJS-12 was more sensitive to change 
in men (d = 0.22) than in women (d = 0.14). The FJS-12 
showed higher effect sizes than the ohS (0.26 vs 0.19) 
in patients aged below 70 years. In those patients aged 
above 70 years there was only very little improvement 
found in this follow-up period with an effect size of 
d = 0.01 for the ohS and d = 0.07 for the FJS-12.
a large proportion of patients reported a single comor-
bidity (high blood pressure), which was unlikely to influ-
ence patient-reported pain and function following hip 
replacement. We therefore dichotomised our dataset 
based on patients having no/one comorbidity or multiple 
comorbidities. This produced similarly sized groups, 
which offered the best estimates for effect sizes. We found 
that in patients with no/one comorbid condition, the 
table I. Patient characteristics (n = 193).
Mean age (sd); range 67.6 (10.5); 28 to 91
Gender (%) women/men 116 (60.1)/77 (39.9)
Side (%): left/right 57.6/42.4
mean body mass index (sd); range 27.7 (5.2) 18.2 to 60.6
comorbidity (%): back pain/high blood pressure/depression/heart disease/ 
 diabetes/cancer/liver disease/stomach ulcer/anaemia/kidney disease/liver disease
94 (56.0)/72 (41.1)/33 (20.6)/20 (11.8)/16 (9.6)/12 (7.5)/11 (6.8)/10 
(6.3)/7 (4.4)/2(1.2)/1 (0.6)
sd, standard deviation
table II. Descriptive statistics for the oxford hip Score and the Forgotten Joint Score–12 at six and 12 months post-surgery.
6 months 12 months  
mean oxford hip Score (sd); median; range 40.3 (7.9); 42; 10 to 48 41.1 (7.2); 43; 17 to 48 Effect size d = 0.10 Sample size* n = 787
mean Forgotten Joint Score–12 (sd); median; range 56.8 (30.1); 56; 0 to 100 62.1 (29.0); 65; 0 to 100 Effect size d = 0.17 Sample size* n = 262
*Sample size required to detect a mean change between six and 12 months (t-test for dependent samples, power = 0.80, alpha = 0.05, two-sided);  
sd, Standard deviation
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Boxplot of the oxford hip Score at six and 12 months post-operatively
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Boxplot of the Forgotten Joint Score-12 at six and 12 months post-operatively
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FJS-12 had higher sensitivity to change than the ohS 
(d = 0.25 vs d = 0.11), whereas in those patients with two 
or more comorbid conditions the ohS showed a similar 
change (d = 0.12 vs d = 0.10).
Discussion
These findings suggest that the FJS-12 is more responsive 
to change between six and 12 months after total hip 
arthroplasty than is the ohS. The measured ceiling effect 
for the ohS was twice that of the FJS-12.
a ceiling effect means that several patients score the 
highest possible score achievable with the employed test. 
a ceiling effect occurs when the test items are not chal-
lenging enough for a group of individuals because the 
test has a limited number of difficult items or even an 
inappropriate item selection.11 This will lead to a short-
coming in the discriminative ability of the test to detect 
clinically relevant changes so that if the patient continues 
to improve, the test does not capture that improvement. 
a ceiling effect of 15% is considered the maximum accept-
able cut-off value.12
We found minimal difference in patient post-operative 
outcome as measured with the ohS between six and 12 
months post-hip arthroplasty, however, the FJS-12 
reported a larger change between six and 12 months, 
perhaps more accurately reflecting the changing percep-
tion of the patient as to the impact of the Tha on their 
quality of life. The subgroup comparisons further high-
light this difference, where the FJS-12 offered greater sen-
sitivity to change than did the ohS in younger patients 
(under 70), healthier patients and males, i.e. those most 
likely to achieve high scores.13,14
outcome tools to assess joint arthroplasty first 
appeared in the late 1960s. When the harris hip Score 
was designed (in 1969), its content validity may well have 
been sufficient for the surgical case-mix of that time. 
however, more than 40 years later primary hip arthro-
plasty patients and the lifestyle of that age group has 
changed considerably. Wamper et al15 found a relevant 
ceiling effect after hip arthroplasty in 31 out of 59 studies 
in their meta-analysis of studies reporting harris hip Score 
data. Similarly, the ohS is an ageing tool developed in the 
1990s. It has been well validated, but is increasingly 
understood to suffer from ceiling effects.9,12 a major dif-
ference between the FJS-12 and the ohS is the population 
for which they were designed. The ohS was developed in 
a pre-operative population3 and reflects the symptom 
state at this time. The FJS-12, in contrast, was designed in 
a post-operative population and reflects the symptom 
state following surgery. This, in principle, should allow 
more measurement variation for higher level function and 
display a lesser ceiling effect, as is seen in Figures 1 and 2.
The Forgotten Joint Score was formally introduced in 
20127 and various groups have described the measurement 
properties of the FJS-12 in knee arthroplasty;6,8 however, 
there is a lack of literature as to the score measurement 
properties following total hip arthroplasty. The original 
paper described similar ceiling and floor effects to the cur-
rent data in the United Kingdom (9.3 and 3.3 %, respec-
tively) in a Swiss population, although at a longer mean 
follow-up period of 3 years. matsumoto et al16 recently vali-
dated a translated version of the FJS-12 in a Japanese hip 
arthroplasty population of 108 patients. These authors 
reported a single post-operative time point analysis com-
paring the FJS-12 to Womac and JEhQ scores at a mean 
follow-up of 30 months (with a wide follow-up time point 
range of one to 180 months). The authors reported a lower 
ceiling effect in the FJS-12 compared with the other meas-
ures, but did not report the percentage of patients achiev-
ing the top score, making direct comparisons difficult. 
homma et al17 included the FJS-12 as an outcome metric in 
a study evaluating the effect of the surgical approach on lat-
eral femoral cutaneous nerve injury rates, again in a Japanese 
population, of 122 patients. measurement properties of the 
score were not evaluated, but the outcome scores pre-
sented for patients (post-operative FJS-12 of 64.3) are simi-
lar to those which we report in this United Kingdom 
population (62.1) and to those which Behrend et  al7 
reported in the original Swiss population (59.8).
The strengths of this study include the first presenta-
tion of linked post-operative FJS-12 outcome data at six 
and 12 months following total hip arthroplasty. The cur-
rent study is also the first specific evaluation of the meth-
odological qualities of this scoring system in a United 
Kingdom or European population of hip arthroplasty 
patients (aside from the original Swiss population). 
limitations of this work include the restricted time points 
available for analysis. It would be useful to identify 
responsiveness over a longer post-operative timeframe, 
though 12 months is the typical outcome timeframe 
reported in the orthopaedic literature. In addition, the 
fact that the outcome scores presented herein are similar 
to those reported in differing populations at three years 
suggests that there is little further change in symptom-
ology, although detailed investigation is required to con-
firm this. Furthermore, the FJS-12 was described as a 
post-operative outcome score and can be contrasted 
against healthy control population scores to offer con-
text. Use of pre-operative data, however, would offer 
additional perspective in terms of assessing change in 
score following surgery. We suggest this as an avenue for 
future research.
Use of a more sensitive score that is not restricted by 
ceiling effects has material implications, both in detecting 
differences in patient outcome/function over time, and in 
the numbers of patients needed in a study to detect a dif-
ference in outcome between groups. The results we 
report herein suggest that around half the number of par-
ticipants would be required to power a superiority design 
randomised trial when using the FJS-12 compared with 
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the ohS. There is seemingly little difference in the effect 
sizes we report (0.10 and 0.17) but this translates as very 
different sample size requirements in terms of numbers 
of participants; this is because the association between 
effect size and sample size is essentially exponential. Use 
of an outcome measure with greater measurement range 
and precision allows for more specific studies with smaller 
numbers of participants, which has significant benefits 
for researchers and funders, allowing for quicker and 
cheaper studies.
our findings suggest that the FJS-12 is more respon-
sive to change between six and 12 months after total hip 
arthroplasty than is the ohS. The measured ceiling effect 
for the ohS was twice that of the FJS-12. The difference in 
effect size of change results in substantial differences in 
required sample size if aiming to detect change between 
these two time points. This has important implications 
for powering clinical trials with patient reported out-
comes as the primary outcome.
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